MC Development
The company «MC Development” together with A.E. Arbuzov IOPC of Russian Academy of Sciences is developing an innovative drug for the prevention and treatment of Alzheimer’s disease. The results of the experiments in vivo indicate the potential ability of the active substance to inhibit the progression of the disease in mice.
In partnership with AVVA RUS
Our main partner is the licensed Russian-Swiss pharmaceutical production site of JSC AVVA RUS who provides manufacturing services to us. The company has a system for organizing production and quality control in accordance with current GMP standards.
